{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-076592","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.533753+00:00","generated_at":"2026-05-15T23:47:35.518009+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"confidence":"high","headline":"Alpha Teknova reports Q4 and FY2025 revenue growth, provides 2026 guidance of $42-44M","bullets":["Full year 2025 total revenue $40.5M, up 7% from $37.7M in 2024.","Q4 2025 revenue $10.0M, up 8% from $9.3M in Q4 2024.","Clinical Solutions revenue up 47% in Q4 to $2.7M; 25% annual growth in Clinical Solutions customers.","Net loss improved to $17.3M in 2025 from $26.7M in 2024; Adjusted EBITDA improved to -$6.7M from -$14.5M.","Company expects 2026 revenue of $42-44M and free cash outflow less than $10M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-076592","json":"https://secwatch.observer/filing/0001193125-26-076592.json","markdown":"https://secwatch.observer/filing/0001193125-26-076592.md","text":"https://secwatch.observer/filing/0001193125-26-076592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/0001193125-26-076592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000119312526076592/tkno-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T23:47:35.518009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}